July 18, 2019
A Scalable Adenovirus Production Process, from Cell Culture to Purified Bulk
Åsa Hagner-McWhirter, Gustaf Ahlén, Magnus Bergman, Eva Blanck, Sara Häggblad-Sahlberg, Pelle Sjöholm, Maria Soultsioti, Sravani Musunuri, Elisabeth Wallby, Anna Åkerblom, Åsa Lagerlöf, Mats Lundgren, and Anita Sohlbrand,
,Cytiva

Adenovirus (AdV) vectors are commonly used in cancer gene therapy trials and evaluated for use in vaccines for various diseases. In this study, we have combined technical evaluation of process steps and process economy calculations, from AdV production in cell culture to purified bulk product in up to 10 L scale. Human AdV5, expressing the green fluorescent protein (GFP), was used for process development.
View Presentation